Author:
Shobeiri Parnian,Rezaei Nima
Publisher
Springer International Publishing
Reference15 articles.
1. Amano E, Horino T, Ichii O, Inotani S, Matsumoto T, Hamada-Ode K et al (2018) Hypereosinophilic syndrome manifested as eosinophilic gastroenteritis and colitis in a patient undergoing hemodialysis. Renal Replacement Therapy 4(1):38
2. Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 54(1):1–27
3. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214
4. Cools J, Stover EH, Gilliland DG (2006) Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia. Methods Mol Med 125:177–187
5. Dahabreh IJ, Giannouli S, Zoi C, Zoi K, Voulgarelis M, Moutsopoulos HM (2007) Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics. Medicine 86(6):344–354